Skip to main content

Podcasts

Podcasts
In this first installment of the Great Debates in Pharmacy series, follow along and answer questions as we explore what determines an outstanding pharmacist.
Podcasts
Peter Pitts, former associate commissioner with the FDA and president of the Center for Medicine in the Public Interest, discusses why CBD remains unlawful under FDA regulations to be marketed as a dietary supplement, regardless of whether or not the substances are hemp derived.
Podcasts
Peter Pitts, former associate commissioner at the US FDA and president of the Center for Medicine in the Public Interest, discusses why the FDA pulled a large quantity of a blood pressure drugs off the market and why it is important to understand.  
Back to Top